Dr James Lundin Rungee, MD | |
1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129-2567 | |
(615) 896-6800 | |
(615) 895-8890 |
Full Name | Dr James Lundin Rungee |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 39 Years |
Location | 1800 Medical Center Pkwy, Murfreesboro, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285627406 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | MD20993 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tennessee Orthopaedic Alliance Pa | 5193625069 | 308 |
News Archive
Cardiac researchers at the University of Pennsylvania have received a $2.1 million grant from the National Institutes of Health (NIH) to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.
A collaboration of 32 researchers in seven countries, led by scientists at Mayo Clinic's campus in Florida, has found a genetic mutation they say confers a risk for development of Parkinson's disease earlier than usual.
There is a very real danger that by the time policy makers get around to reading and understanding this section of law (on accountable care organizations) that the health care marketplace will have irreversibly changed (Dustin Corcoran, 9/30).
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1a trial of ViaDerm-GLP1 agonist which is being developed for the treatment of diabetes mellitus type II.
› Verified 8 days ago
Entity Name | Tennessee Orthopaedic Alliance Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538153937 PECOS PAC ID: 5193625069 Enrollment ID: O20040109000069 |
News Archive
Cardiac researchers at the University of Pennsylvania have received a $2.1 million grant from the National Institutes of Health (NIH) to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.
A collaboration of 32 researchers in seven countries, led by scientists at Mayo Clinic's campus in Florida, has found a genetic mutation they say confers a risk for development of Parkinson's disease earlier than usual.
There is a very real danger that by the time policy makers get around to reading and understanding this section of law (on accountable care organizations) that the health care marketplace will have irreversibly changed (Dustin Corcoran, 9/30).
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1a trial of ViaDerm-GLP1 agonist which is being developed for the treatment of diabetes mellitus type II.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James Lundin Rungee, MD Po Box 306556, Nashville, TN 37230-6556 Ph: (865) 243-8153 | Dr James Lundin Rungee, MD 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129-2567 Ph: (615) 896-6800 |
News Archive
Cardiac researchers at the University of Pennsylvania have received a $2.1 million grant from the National Institutes of Health (NIH) to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.
A collaboration of 32 researchers in seven countries, led by scientists at Mayo Clinic's campus in Florida, has found a genetic mutation they say confers a risk for development of Parkinson's disease earlier than usual.
There is a very real danger that by the time policy makers get around to reading and understanding this section of law (on accountable care organizations) that the health care marketplace will have irreversibly changed (Dustin Corcoran, 9/30).
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1a trial of ViaDerm-GLP1 agonist which is being developed for the treatment of diabetes mellitus type II.
› Verified 8 days ago
Dr. Edwin Ray Lowery, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1010 N Highland Ave, Murfreesboro, TN 37130 Phone: 615-896-6800 Fax: 615-320-1229 | |
Nicholas Alan Shepard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Dr. William Henry Ledbetter, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 | |
Dr. Kyle Steven Joyner, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Dr. Brad Michael Askam, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 200, Murfreesboro, TN 37129 Phone: 615-896-6800 Fax: 615-895-8890 | |
Dr. Richard Alan Rogers, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 Medical Center Pkwy, Suite 200, Murfreesboro, TN 37129 Phone: 615-896-6800 |